Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation

• 收藏
• 分享

专利权人:

Univeristy of Chicago

发明人:

Yuan, Chun-Su,Wang, Chong-Zhi,Gu, Maojian,Lin, Dong-Hai

申请号：

AU2013257211

公开号：

AU2013257211A1

申请日:

2013.03.13

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein. Such pharmaceutical composition may be used for treating and preventing opioid-induced side effects in patients, and may be provided to chronic opioid users as well.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/